Quinagolide

Share on Facebook Share on Twitter Email

A dopamine receptor agonist, very similar to bromocriptine, used to reduce elevated prolactin concentrations in certain types of infertility. It is available as tablets on prescription only.

Side effects:
include nausea, headache, dizziness, fatigue, loss of appetite, gastrointestinal disturbances, insomnia, oedema (swelling), flushing, nasal congestion, and low blood pressure.

Precautions:
quinagolide should not be taken by people with kidney or liver impairment and should be used with caution in those who have a history of psychiatric disorders. Women should stop taking the drug if they become pregnant.

Interactions with other drugs:

Dopamine antagonists: may reduce its effect.

Proprietary preparation:
Norprolac.

Previous:quetiapine, Quinoderm, Qlaira
Next:quinapril, quinine, quinolones
Top
Quinagolide
Systematic (IUPAC) name
N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status Prescription only
Routes Oral
Identifiers
CAS number 87056-78-8 N
ATC code G02CB04
PubChem CID 55645
ChemSpider 2343034 YesY
UNII 80Q9QWN15M YesY
KEGG D07217 YesY
ChEMBL CHEMBL290962 YesY
Chemical data
Formula C20H33N3O3S 
Mol. mass 395.56 g/mol
 N (what is this?)  (verify)

Quinagolide (Norprolac) is a selective, D2 receptor agonist that is used for the treatment of elevated levels of prolactin.[1]

See also

References

  1. ^ Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2265.2000.01016.x/full. 



Post a question - any question - to the WikiAnswers community:

Copyrights: